In this study, we synthesized a novel and more stable small-molecule STING agonist, D166, and demonstrated its therapeutic efficacy for pancreatic cancer using both pancreatic tumor organoids and mouse models. This evidence concerns the gene STING1 and familial pancreatic carcinoma.